Halder; Arindam
Patent Applications and Registrations
Patent applications and USPTO patent grants for Halder; Arindam.The latest application filed is for "systems and methods for recommending execution environment for analysing sensor observational data".
- Halder; Arindam - Kolkata IN
- Halder; Arindam - Nagoya JP
- Halder; Arindam - Baroda IN
- HALDER; Arindam - Nagoya-shi JP
| Patent | Date |
|---|---|
| Systems and methods for recommending execution environment for analysing sensor observational data Grant 11,449,522 - Chattopadhyay , et al. September 20, 2 | 2022-09-20 |
| Systems And Methods For Recommending Execution Environment For Analysing Sensor Observational Data App 20220269689 - CHATTOPADHYAY; Tanushyam ; et al. | 2022-08-25 |
| Optical fiber laser device Grant 11,424,589 - Hasegawa , et al. August 23, 2 | 2022-08-23 |
| Ophthalmic solution of bimatoprost Grant 11,241,443 - Khopade , et al. February 8, 2 | 2022-02-08 |
| Ophthalmic Solution Of Difluprednate App 20210353540 - Khopade; Ajay Jaysingh ; et al. | 2021-11-18 |
| Method Of Increasing Bioavailability And/or Prolonging Ophthalmic Action Of A Drug App 20210308130 - Khopade; Ajay Jaysingh ; et al. | 2021-10-07 |
| Ophthalmic solution of difluprednate Grant 11,103,451 - Khopade , et al. August 31, 2 | 2021-08-31 |
| Method of increasing bioavailability and/or prolonging ophthalmic action of a drug Grant 11,058,684 - Khopade , et al. July 13, 2 | 2021-07-13 |
| Ophthalmic solution of difluprednate Grant 11,000,475 - Khopade , et al. May 11, 2 | 2021-05-11 |
| Optical Fiber Laser Device App 20200358245 - HASEGAWA; Kazuo ; et al. | 2020-11-12 |
| Drug Loaded Nanoresin Particles App 20200170951 - Khopade; Ajay Jaysingh ; et al. | 2020-06-04 |
| Ophthalmic Solution Of Bimatoprost App 20200016169 - KHOPADE; Ajay Jaysingh ; et al. | 2020-01-16 |
| Viscoelastic Gel of Liraglutide Adapted for Once-Weekly or Once Bi-Weekly Administration App 20190105268 - Khopade; Ajay Jaysingh ; et al. | 2019-04-11 |
| Method Of Increasing Bioavailability And/or Prolonging Ophthalmic Action Of A Drug App 20190070176 - Khopade; Ajay Jaysingh ; et al. | 2019-03-07 |
| Drug Loaded Nanoresin Particles App 20190008772 - Khopade; Ajay Jaysingh ; et al. | 2019-01-10 |
| Method of increasing bioavailability and/or prolonging ophthalmic action of a drug Grant 10,172,852 - Khopade , et al. J | 2019-01-08 |
| Ophthalmic Solution Of Difluprednate App 20180311159 - Khopade; Ajay Jaysingh ; et al. | 2018-11-01 |
| Ophthalmic Solution Of Difluprednate App 20180296571 - Khopade; Ajay Jaysingh ; et al. | 2018-10-18 |
| Long Acting Liraglutide Compositions App 20180221451 - Khopade; Ajay Jaysingh ; et al. | 2018-08-09 |
| Long Acting Liraglutide Compositions App 20180169010 - Khopade; Ajay Jaysingh ; et al. | 2018-06-21 |
| Method Of Increasing Bioavailability And/or Prolonging Ophthalmic Action Of A Drug App 20170239243 - Khopade; Ajay Jaysingh ; et al. | 2017-08-24 |
| Ophthalmic composition comprising a prostaglandin Grant 9,629,852 - Khopade , et al. April 25, 2 | 2017-04-25 |
| Ophthalmic composition comprising a prostaglandin Grant 9,539,262 - Khopade , et al. January 10, 2 | 2017-01-10 |
| Ophthalmic Composition Comprising A Prostaglandin App 20150290216 - KHOPADE; Ajay Jaysingh ; et al. | 2015-10-15 |
| Novel Ophthalmic Compositions App 20130267591 - Khopade; Ajay Jaysingh ; et al. | 2013-10-10 |
| Ophthalmic Composition App 20110003816 - Halder; Arindam ; et al. | 2011-01-06 |
| Ophthalmic Composition Comprising A Prostaglandin App 20100137432 - Khopade; Ajay Jaysingh ; et al. | 2010-06-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 